Health in Bolivia 1,149 indicators covering health for Bolivia. IndicatorLatest Year10-yr change Rank Tb patients living with hiv receiving art 266 2017 up 26,500.0% 63rd HIV-positive TB patients on ART (antiretroviral therapy) 65.0% 2024 down 4.4% 134th Hospital beds 14.91 2023 up 36.9% 107th Treatment success rate for patients treated for MDR-TB 42.0% 2022 down 37.3% 149th New leprosy case detection rate per 1 000 000 population 2.1 2024 — 74th Prevalence of wasting, weight for height 2.0% 2016 up 42.9% 79th Earthquake deaths 105 1998 — 6th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 59.0% 2025 — 143rd International Health Regulations core capacity scores, SPAR version 50 2025 — 85th Prevalence of underweight, weight for age 3.4% 2016 down 24.4% 72nd Leprosy registered prevalence rate per 1 000 000 population 2.5 2024 — 72nd Leprosy - Number of new leprosy cases among children 0 2024 — 69th Leprosy - Number of cases registered for treatment 31 2024 — 66th New leprosy child case detection rate (less than 15 years of age) per 0 2024 — 69th Children (0-14) living with HIV 700 2024 down 30.0% 61st Ipv1 number unvaccinated 70,372 2023 up 302.7% 41st Children living with hiv 700 2024 down 30.0% 61st Contraceptive prevalence, any method 66.5% 2016 up 9.7% 33rd Children (ages 0-14) newly infected with HIV 100 2024 down 50.0% 51st Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Number of children newly infected with hiv 100 2024 down 50.0% 51st Share of children under fifteen years old with hiv 59.5 2024 down 58.3% 56th Number of female leprosy new cases 15 2024 down 54.5% 58th Estimated number of malaria deaths 12 2024 up 200.0% 58th Estimated number of malaria cases 21,560 2024 up 96.1% 56th National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 up 100.0% 1st Contraceptive prevalence, any modern method 45.1% 2016 up 30.3% 61st Number of prevalent tuberculosis cases 20,000 2014 down 9.1% 59th Estimated malaria incidence 3.83 2024 up 71.4% 54th Estimated malaria mortality rate 0.2131 2024 up 162.2% 57th Number of new G2D leprosy cases 4 2024 up 33.3% 61st Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0.322 2024 up 16.9% 64th Inflation-adjusted prices for most sold brand of cigarettes: Prices 5.98 2022 up 78.5% 99th Taxes as a % of price: total tax 31.5% 2022 down 20.1% 150th Taxes as a % of price: value added tax 11.5% 2022 unchanged 111th Taxes as a % of price: ad valorem excise 0.0% 2022 down 100.0% 106th Taxes as a % of price: specific excise 20.0% 2022 — 101st Taxes as a % of price: import duties 0.0% 2022 — 37th Taxes as a % of price: other taxes 0.0% 2022 — 56th Vitamin A supplementation coverage rate 28.0% 2023 down 30.0% 42nd Inflation-adjusted prices for most sold brand of cigarettes: Price in 15 2022 up 40.3% 118th Estimated number of children needing antiretroviral therapy based on 1,200 2025 down 25.0% 51st Prevalence of severe wasting, weight for height 0.9% 2016 up 80.0% 46th Physical activity policies for activie societies 20 2023 unchanged 2nd Physical activity policies focused on active systems 33 2023 up 65.0% 1st Number of deaths from malaria who 12 2024 up 200.0% 58th Death rate from malaria 0.2131 2024 up 162.2% 57th Incidence of malaria 3.83 2024 up 71.7% 54th Share of one year olds who received the final dose of pneumococcal vac 59 2024 up 5.4% 133rd Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 59 2024 up 5.4% 133rd Estimated antiretroviral therapy coverage among children 41 2025 up 272.7% 56th Death rate from poisonings 0.4 2021 down 33.3% 96th Rotavirus number unvaccinated 75,398 2023 up 89.3% 36th Share of deaths registered 64.79 2019 — 130th Prevalence of stunting, height for age 16.1% 2016 down 40.6% 58th Affordability - percentage of GDP per capita required to purchase 5.51 2020 up 24.7% 63rd Malaria cases reported 15,704 2024 up 112.2% 55th Deaths and missing persons due to natural disasters 87.67 2021 up 11,589.3% 2nd Mean systolic blood pressure 120.9 2009 down 0.3% 156th Mean fasting blood glucose (mmol/l) 5.4 2009 up 1.9% 71st ← Previous Page 15 of 20 Next →